Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Exagen Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Exagen Inc. held its 2026 annual stockholder meeting on June 9, 2026, electing two Class I directors for three-year terms. Tina S. Nova, Ph.D. and Scott Kahn, Ph.D. were elected with strong stockholder support, reflecting confidence in the company's strategic direction.
Key Takeaways
Tina S. Nova, Ph.D. elected as Class I director with 8,094,349 votes for and 220,954 withheld, demonstrating overwhelming stockholder support
Scott Kahn, Ph.D. elected as Class I director with 6,295,837 votes for and 2,019,466 withheld, indicating solid but comparatively lower support
2 more takeaways